APUS 株価推移チャート
APUS 収入
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
終値： Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
アフターマーケット：Apr 16, 18:08:32 GMT-4
戻る
Apimeds Pharmaceuticals US Inc (APUS) 収入
主要データ
前終値
$1.88
始値
$1.69
当日レンジ
$1.69 - $1.88
52週レンジ
$1.6 - $40.31
取引高
31.5K
平均取引高
17.9K
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$23.6M
APUSとは何ですか？
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
